SCHEMBL20158992

SCHEMBL20158992

Cc1c(CN2CCN(c3ccccc3C#N)CC2)cc(C(=O)N2CCN(c3ccccc3)CC2)n1C

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 6/20 0.84
RPTOR Q8N122 6/20 0.84
MLST8 Q9BVC4 6/20 0.84
HTR7 P34969 1/20 0.53
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
DRD4 P21917 5/20 0.44
DRD2 P14416 5/20 0.44
DRD3 P35462 3/20 0.44
HTR2A P28223 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
THPO P40225 1/20 0.44
HIF1A Q16665 1/20 0.44
TP53 P04637 1/20 0.44
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20159082 0.95 MTOR (0.75) MTORRPTORMLST8HTR7DRD4
SCHEMBL20158995 0.94 MTOR (0.74) MTORRPTORMLST8HTR7DRD4
SCHEMBL20158988 0.93 MTOR (0.73) MTORRPTORMLST8HTR7MEN1
SCHEMBL20159227 0.91 MTOR (1.00) MTORRPTORMLST8HTR7MEN1
SCHEMBL20159090 0.90 MTOR (0.71) MTORRPTORMLST8HTR7DRD4
SCHEMBL20141378 0.90 MTOR (0.69) MTORRPTORMLST8HTR7MEN1
SCHEMBL20141020 0.89 MTOR (0.68) MTORRPTORMLST8HTR7DRD4
SCHEMBL20159217 0.88 MTOR (0.74) MTORRPTORMLST8HTR7DRD4
SCHEMBL20140555 0.87 MTOR (0.78) MTORRPTORMLST8HTR7MEN1
SCHEMBL20159132 0.87 MTOR (0.65) MTORRPTORMLST8HTR7DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed